174 related articles for article (PubMed ID: 35008827)
1. Clinical Significance of Stem Cell Biomarkers EpCAM, LGR5 and LGR4 mRNA Levels in Lymph Nodes of Colon Cancer Patients.
AbdelMageed M; Ismail HTH; Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008827
[TBL] [Abstract][Full Text] [Related]
2. The Chemokine CXCL16 Is a New Biomarker for Lymph Node Analysis of Colon Cancer Outcome.
AbdelMageed M; Ali H; Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31752131
[TBL] [Abstract][Full Text] [Related]
3. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J
Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Significance of
Ismail HTH; AbdelMageed M; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562947
[TBL] [Abstract][Full Text] [Related]
5. Lymph node CXCL17 messenger RNA: A new prognostic biomarker for colon cancer.
Rashad Y; Olsson L; Israelsson A; Öberg Å; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
Tumour Biol; 2018 Sep; 40(9):1010428318799251. PubMed ID: 30198422
[TBL] [Abstract][Full Text] [Related]
6. Utility of G protein-coupled receptor 35 expression for predicting outcome in colon cancer.
Ali H; AbdelMageed M; Olsson L; Israelsson A; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
Tumour Biol; 2019 Jun; 41(6):1010428319858885. PubMed ID: 31250711
[TBL] [Abstract][Full Text] [Related]
7. The myeloid cell biomarker EMR1 is ectopically expressed in colon cancer.
Ali H; Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
Tumour Biol; 2021; 43(1):209-223. PubMed ID: 34486997
[TBL] [Abstract][Full Text] [Related]
8. Evaluating macrophage migration inhibitory factor 1 expression as a prognostic biomarker in colon cancer.
Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
Tumour Biol; 2020 Jun; 42(6):1010428320924524. PubMed ID: 32515296
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of putative markers of cancer stem cells in gastric cancer: A retrospective cohort study.
Chen XL; Chen XZ; Wang YG; He D; Lu ZH; Liu K; Zhang WH; Wang W; Li CC; Xue L; Zhao LY; Yang K; Liu JP; Zhou ZG; Hu JK; Mo XM
Oncotarget; 2016 Sep; 7(38):62049-62069. PubMed ID: 27557490
[TBL] [Abstract][Full Text] [Related]
10. LGR5 expression predicts peritoneal recurrence after curative resection of primary colon cancer.
Nagata H; Ishihara S; Abe H; Ushiku T; Kishikawa J; Tanaka T; Hata K; Kawai K; Fukayama M; Nozawa H
Br J Cancer; 2019 May; 120(10):996-1002. PubMed ID: 31000786
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients.
Rot S; Kaune T; Taubert H; Greither T; Kotrba J; Güttler A; Wichmann H; Bilkenroth U; Wienke A; Al-Nawas B; Bache M; Vordermark D; Wickenhauser C; Bethmann D; Eckert AW; Kappler M
BMC Cancer; 2019 Feb; 19(1):155. PubMed ID: 30770730
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of cancer stem cells in digestive cancers: acquisition of stemness and prognostic impact.
Tsunedomi R; Yoshimura K; Suzuki N; Hazama S; Nagano H
Surg Today; 2020 Dec; 50(12):1560-1577. PubMed ID: 32025858
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of leucine-rich-repeat-containing G-protein-coupled receptor 5, an intestinal stem cell marker, in gastric carcinomas.
Jang BG; Lee BL; Kim WH
Gastric Cancer; 2016 Jul; 19(3):767-77. PubMed ID: 26386561
[TBL] [Abstract][Full Text] [Related]
14. m
Zhang Y; Kang M; Zhang B; Meng F; Song J; Kaneko H; Shimamoto F; Tang B
Mol Cancer; 2019 Dec; 18(1):185. PubMed ID: 31849331
[TBL] [Abstract][Full Text] [Related]
15. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
Stanisavljević L; Myklebust MP; Leh S; Dahl O
Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
[TBL] [Abstract][Full Text] [Related]
16. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
17. The potential of cytokeratin 20 and mucin 2 mRNA as metastasis markers in regional lymph nodes of colon cancer patients investigated by quantitative RT-PCR.
Nordgård O; Oltedal S; Kørner H; Aasprong OG; Tjensvoll K; Gilje B; Heikkilä R
Int J Colorectal Dis; 2009 Mar; 24(3):261-8. PubMed ID: 19119477
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients.
Mirzaei A; Tavoosidana G; Modarressi MH; Rad AA; Fazeli MS; Shirkoohi R; Tavakoli-Yaraki M; Madjd Z
Tumour Biol; 2015 Jun; 36(6):4801-10. PubMed ID: 25631749
[TBL] [Abstract][Full Text] [Related]
19. A new insight into cancer stem cell markers: Could local and circulating cancer stem cell markers correlate in colorectal cancer?
Mirzaei A; Tavoosidana G; Rad AA; Rezaei F; Tavakoli-Yaraki M; Kadijani AA; Khalili E; Madjd Z
Tumour Biol; 2016 Feb; 37(2):2405-14. PubMed ID: 26383518
[TBL] [Abstract][Full Text] [Related]
20. The heparan sulfate proteoglycan syndecan-1 regulates colon cancer stem cell function via a focal adhesion kinase-Wnt signaling axis.
Kumar Katakam S; Tria V; Sim WC; Yip GW; Molgora S; Karnavas T; Elghonaimy EA; Pelucchi P; Piscitelli E; Ibrahim SA; Zucchi I; Reinbold R; Greve B; Götte M
FEBS J; 2021 Jan; 288(2):486-506. PubMed ID: 32367652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
